QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.72%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 SOC TelemedAmerican Renal AssociatesTivity HealthHemaCareViemed Healthcare
SymbolNASDAQ:TLMDNYSE:ARANASDAQ:TVTYOTCMKTS:HEMANASDAQ:VMD
Price Information
Current Price$6.94$11.52$23.34$25.31$9.70
52 Week RangeBuyHoldBuyN/ABuy
MarketRank™
Overall Score1.71.01.00.51.1
Analysis Score3.41.01.30.02.3
Community Score4.32.32.32.41.2
Dividend Score0.00.00.00.00.0
Ownership Score0.01.71.70.00.8
Earnings & Valuation Score0.60.00.00.01.3
Analyst Ratings
Consensus RecommendationBuyHoldBuyN/ABuy
Consensus Price Target$11.40$7.00$22.13N/A$12.00
% Upside from Price Target64.27% upside-39.24% downside-5.21% downsideN/A23.71% upside
Trade Information
Market Cap$621.99 million$397.94 million$1.13 billion$346.52 million$380.09 million
BetaN/A1.112.491.471.52
Average Volume496,770106,940523,15139,950210,867
Sales & Book Value
Annual RevenueN/A$822.52 million$1.13 billionN/A$80.26 million
Price / SalesN/A0.481.00N/A4.74
Cashflow$0.00 per share$1.69 per share$3.60 per shareN/A$0.45 per share
Price / Cash2,571.926.806.48N/A21.56
Book Value$0.61 per share$2.59 per share$4.73 per shareN/A$1.15 per share
Price / BookN/A4.454.93N/A8.43
Profitability
Net Income$20,000.00$-13,790,000.00$-286,820,000.00N/A$8.52 million
EPSN/A$0.26$2.02N/A$0.21
Trailing P/E Ratio0.00N/AN/A0.0013.47
Forward P/E RatioN/AN/A18.0931.29
P/E GrowthN/AN/A1.60N/AN/A
Net MarginsN/A-2.04%-47.44%N/A23.73%
Return on Equity (ROE)N/A-3.56%128.43%N/A48.32%
Return on Assets (ROA)N/A-0.24%6.11%N/A29.17%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A7.54%435.23%N/A0.10%
Current Ratio0.24%1.05%1.04%N/A1.65%
Quick Ratio0.24%1.02%0.88%N/A1.56%
Ownership Information
Institutional Ownership Percentage20.70%78.42%91.57%N/A40.04%
Insider Ownership PercentageN/A9.50%11.77%26.20%N/A
Miscellaneous
Employees2874,9771,000N/A499
Shares Outstanding89.62 million34.54 million48.62 million13.69 million39.19 million
Next Earnings Date3/8/2021 (Estimated)3/15/2021 (Estimated)5/5/2021 (Estimated)N/A5/3/2021 (Estimated)
OptionableOptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.